Macrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamo
Authors
John Campbell (ORCID: https://orcid.org/0000-0001-7752-7642)
Macrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamo
John Campbell, Sharon Zahra, Christopher John Weir, Ashley P Jones et al.
Citations
8 citations
Journal
BMJ Open
Topics
Drug-Induced Hepatotoxicity and Protection
Field-Weighted Citation Impact (FWCI)
3.73
article
Macrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamo
John Campbell, Sharon Zahra, Christopher John Weir, Ashley P Jones, Anna K. Heye, Aryelly Rodríguez, Ellise Clarke, James Coulson, Alison Grant, Garry Tucker, Julia Boyd, Rachel Woods, Joanna K. Moore, James A. Hutchinson, Kim Walker, Melisande Addison, Maria Elena Candela, Stuart J. Forbes, Robert J. Fontana, Chris Humphries, Julia Grahamslaw, Lesley Briody, Angela Thomas, James W. Dear, Guruprasad Padur Aithal, Nicholas Downing-James, F. L. Mitchell, A Geddes, Alice Riddell
article en
8 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 14(12)
Institutions
Nottingham University Hospitals NHS Trust (GB), Edinburgh Royal Infirmary (GB), MRC Centre for Regenerative Medicine (GB), Queen's Medical Centre (GB), Nottingham Biomedical Research Centre (GB), The Queen's Medical Research Institute (GB), Scottish National Blood Transfusion Service (GB), University of Edinburgh (GB)